Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
UPR

Uniphar plc

UPRLSEIrelandHealthcareMedical DistributionFTSE AIM 100

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The…more

P/E18.89xP/B2.51xROIC10.4%Dividend yield0.5%
£906.31M
Market Cap
EV: £1.34B
MOM9
QUAL1
VAL5
RSK3
UPR
£906.31M
Market Cap · EV £1.34B

Uniphar plc

MOM9
QUAL1
VAL5
RSK3

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The…more

Latest RNS from Uniphar plc

All UPR news → · RNS daily feed

Analyst consensus: Buy

As of 22 Sept 2026, 3 analysts rate Uniphar plc a Buy, with 67% buy ratings and a mean price target of 419p (range 372p–466p), +23% vs the current price.

Strong buy: 0Buy: 2Hold: 1Sell: 0Strong sell: 0

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 362p against a current price of 341p (+6%), based on EV/EBITDA.

More Healthcare companies